159 related articles for article (PubMed ID: 25901734)
1. Effect of platelet receptor gene polymorphisms on outcomes in ST-elevation myocardial infarction patients after percutaneous coronary intervention.
Zhang JH; Wang J; Tang XF; Yao Y; Zhang Y; Ma YL; Xu B; Gao RL; Song L; Gao Z; Chen J; Wu Y; Yang YJ; Meng XM; Yuan JQ
Platelets; 2016; 27(1):75-9. PubMed ID: 25901734
[TBL] [Abstract][Full Text] [Related]
2. Platelet gene polymorphisms and risk of bleeding in patients undergoing elective coronary angiography: a genetic substudy of the PRAGUE-8 trial.
Motovska Z; Kvasnicka J; Hajkova J; Kala P; Simek S; Bobcikova P; Petr R; Bilkova D; Poloczek M; Miklik R; Fischerova M; Maly M; Widimsky P
Atherosclerosis; 2010 Oct; 212(2):548-52. PubMed ID: 20691446
[TBL] [Abstract][Full Text] [Related]
3. Relationship between ABCB1 polymorphisms, thromboelastography and risk of bleeding events in clopidogrel-treated patients with ST-elevation myocardial infarction.
Zhang JH; Tang XF; Zhang Y; Wang J; Yao Y; Ma YL; Xu B; Gao RL; Gao Z; Chen J; Song L; Wu Y; Meng XM; Yuan JQ
Thromb Res; 2014 Nov; 134(5):970-5. PubMed ID: 25217066
[TBL] [Abstract][Full Text] [Related]
4. Platelet glycoprotein GP VI 13254C allele is an independent risk factor of premature myocardial infarction.
Motovska Z; Kvasnicka J; Widimsky P; Petr R; Hajkova J; Bobcikova P; Osmancik P; Odvodyova D; Katina S
Thromb Res; 2010 Feb; 125(2):e61-4. PubMed ID: 19786296
[TBL] [Abstract][Full Text] [Related]
5. Association of polymorphisms of platelet receptors GPIa (807C>T), GPVI (13254T>C), and P2Y12 (34C>T and H1/H2 haplotype) with increased risk of periprocedural bleeding in patients undergoing coronary angiography/percutaneous coronary intervention.
Sionova M; Blasko P; Jirous S; Vindis D; Rokyta R; Motovska Z
Postepy Kardiol Interwencyjnej; 2017; 13(3):202-209. PubMed ID: 29056992
[TBL] [Abstract][Full Text] [Related]
6. Value of platelet pharmacogenetics in common clinical practice of patients with ST-segment elevation myocardial infarction.
Verschuren JJ; Boden H; Wessels JA; van der Hoeven BL; Trompet S; Heijmans BT; Putter H; Guchelaar HJ; Schalij MJ; Jukema JW
Int J Cardiol; 2013 Sep; 167(6):2882-8. PubMed ID: 22940005
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the F2R IVS-14A/T PAR1 polymorphism with subsequent cardiovascular events and bleeding in patients who have undergone percutaneous coronary intervention.
Friedman EA; Texeira L; Delaney J; Weeke PE; Lynch DR; Kasasbeh E; Song Y; Harrell FE; Denny JC; Hamm HE; Roden DM; Cleator JH
J Thromb Thrombolysis; 2016 May; 41(4):656-62. PubMed ID: 26446588
[TBL] [Abstract][Full Text] [Related]
8. Personalized ADP-receptor inhibition strategy and outcomes following primary PCI for STEMI (PASTOR study).
Mikkelsson J; Paana T; Lepantalo A; Karjalainen PP
Int J Cardiol; 2016 Jan; 202():463-6. PubMed ID: 26436674
[TBL] [Abstract][Full Text] [Related]
9. High post-clopidogrel platelet reactivity assessed by a point-of-care assay predicts long-term clinical outcomes in patients with ST-segment elevation myocardial infarction who underwent primary coronary stenting.
Jin HY; Yang TH; Kim DI; Chung SR; Seo JS; Jang JS; Kim DK; Kim DK; Kim KH; Seol SH; Nam CW; Hur SH; Kim W; Park JS; Kim YJ; Kim DS
Int J Cardiol; 2013 Sep; 167(5):1877-81. PubMed ID: 22682702
[TBL] [Abstract][Full Text] [Related]
10. Prasugrel versus clopidogrel in patients with ST-segment elevation myocardial infarction according to timing of percutaneous coronary intervention: a TRITON-TIMI 38 subgroup analysis (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel-Thrombolysis In Myocardial Infarction 38).
Udell JA; Braunwald E; Antman EM; Murphy SA; Montalescot G; Wiviott SD
JACC Cardiovasc Interv; 2014 Jun; 7(6):604-12. PubMed ID: 24947719
[TBL] [Abstract][Full Text] [Related]
11. Role of glycoprotein Ia gene polymorphisms in determining platelet function in myocardial infarction patients undergoing percutaneous coronary intervention on dual antiplatelet treatment.
Giusti B; Gori AM; Marcucci R; Sestini I; Saracini C; Paniccia R; Poli S; Giglioli C; Valente S; Prisco D; Gensini GF; Abbate R
Atherosclerosis; 2008 Jan; 196(1):341-348. PubMed ID: 17157856
[TBL] [Abstract][Full Text] [Related]
12. Factors Affecting Platelet Reactivity 2 Hours After P2Y₁₂ Receptor Antagonist Loading in Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction - Impact of Pain-to-Loading Time.
Xanthopoulou I; Davlouros P; Tsigkas G; Koutsogiannis N; Patsilinakos S; Deftereos S; Hahalis G; Alexopoulos D
Circ J; 2016; 80(2):442-9. PubMed ID: 26597388
[TBL] [Abstract][Full Text] [Related]
13. A therapeutic window for platelet reactivity for patients undergoing elective percutaneous coronary intervention: results of the ARMYDA-PROVE (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platelet Reactivity for Outcome Validation Effort) study.
Mangiacapra F; Patti G; Barbato E; Peace AJ; Ricottini E; Vizzi V; Gatto L; D'Ambrosio A; De Bruyne B; Wijns W; Di Sciascio G
JACC Cardiovasc Interv; 2012 Mar; 5(3):281-9. PubMed ID: 22440493
[TBL] [Abstract][Full Text] [Related]
14. [Possible Genetic Predictors of Cardiovascular Complications After Coronary Artery Bypass Surgery].
Grinshtein YI; Kosinova AA; Grinshtein IY; Subbotina TN; Savchenko AA
Kardiologiia; 2018 Jul; 58(7):77-84. PubMed ID: 30081812
[TBL] [Abstract][Full Text] [Related]
15. Impact of gene polymorphisms, platelet reactivity, and the SYNTAX score on 1-year clinical outcomes in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention: the GEPRESS study.
Palmerini T; Calabrò P; Piscione F; De Servi S; Cattaneo M; Maffeo D; Toso A; Bartorelli A; Palmieri C; De Carlo M; Capodanno D; Barozzi C; Tomasi L; Della Riva D; Mariani A; Taglieri N; Reggiani LB; Bianchi R; De Rosa R; Mariani M; Podda G; Généreux P; Stone GW; Angiolillo DJ
JACC Cardiovasc Interv; 2014 Oct; 7(10):1117-27. PubMed ID: 25240538
[TBL] [Abstract][Full Text] [Related]
16. Clinical implications of very low on-treatment platelet reactivity in patients treated with thienopyridine: the POBA study (predictor of bleedings with antiplatelet drugs).
Cuisset T; Grosdidier C; Loundou AD; Quilici J; Loosveld M; Camoin L; Pankert M; Beguin S; Lambert M; Morange PE; Bonnet JL; Alessi MC
JACC Cardiovasc Interv; 2013 Aug; 6(8):854-63. PubMed ID: 23968703
[TBL] [Abstract][Full Text] [Related]
17. Platelet effect of prasugrel and ticagrelor in patients with ST-segment elevation myocardial infarction.
Kerneis M; Silvain J; Abtan J; Hauguel M; Barthélémy O; Payot L; Brugier D; Galier S; Collet JP; Montalescot G
Arch Cardiovasc Dis; 2015 Oct; 108(10):502-10. PubMed ID: 26113480
[TBL] [Abstract][Full Text] [Related]
18. Point-of-care assessment of platelet reactivity after clopidogrel to predict myonecrosis in patients undergoing percutaneous coronary intervention.
Mangiacapra F; Barbato E; Patti G; Gatto L; Vizzi V; Ricottini E; D'Ambrosio A; Wijns W; Di Sciascio G
JACC Cardiovasc Interv; 2010 Mar; 3(3):318-23. PubMed ID: 20298992
[TBL] [Abstract][Full Text] [Related]
19. Safety and feasibility of adjunctive antiplatelet therapy with intravenous elinogrel, a direct-acting and reversible P2Y12 ADP-receptor antagonist, before primary percutaneous intervention in patients with ST-elevation myocardial infarction: the Early Rapid ReversAl of platelet thromboSis with intravenous Elinogrel before PCI to optimize reperfusion in acute Myocardial Infarction (ERASE MI) pilot trial.
Berger JS; Roe MT; Gibson CM; Kilaru R; Green CL; Melton L; Blankenship JD; Metzger DC; Granger CB; Gretler DD; Grines CL; Huber K; Zeymer U; Buszman P; Harrington RA; Armstrong PW
Am Heart J; 2009 Dec; 158(6):998-1004.e1. PubMed ID: 19958867
[TBL] [Abstract][Full Text] [Related]
20. Association of mean platelet volume with angiographic thrombus burden and short-term mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Lai HM; Xu R; Yang YN; Ma YT; Li XM; Zhao Q; Chen QJ; Zhai H; Liu F; Chen BD
Catheter Cardiovasc Interv; 2015 Mar; 85 Suppl 1():724-33. PubMed ID: 25630273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
